Invenomic Capital Management’s Macy's M Stock Holding History

Invenomic Capital Management’s Portfolio M Stock Details M Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$9.36M	Sell	397,367 -653,956	-62%	-$13.7M	0.56%	64
2026 Q1	$19M	Buy	1,051,323 +397,664	+61%	+$8.05M	0.87%	43
2025 Q4	$14.4M	Buy	653,659 +1,200	+0.2%	+$24.6K	0.67%	52
2025 Q3	$11.7M	Sell	652,459 -1,222,766	-65%	-$17.3M	0.57%	63
2025 Q2	$21.9M	Buy	1,875,225 +151,011	+9%	+$1.75M	1.24%	24
2025 Q1	$21.7M	Buy	1,724,214 +824,174	+92%	+$12M	1.09%	24
2024 Q4	$15.2M	Buy	900,040 +104,353	+13%	+$1.66M	0.73%	39
2024 Q3	$12.5M	Buy	795,687 +194,443	+32%	+$3.16M	0.69%	51
2024 Q2	$11.5M	Buy	601,244 +267,725	+80%	+$5.11M	0.56%	60
2024 Q1	$6.67M	Sell	333,519 -629,291	-65%	-$12.2M	0.35%	86
2023 Q4	$19.4M	Buy	+962,810	New	+$13.9M	0.88%	34

Other funds holding M

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

RAM

RWC Asset Management London, United Kingdom $2.64B AUM 33.18% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Invenomic Capital Management's M Position: Q2 2026 in Review

Invenomic Capital Management reduced its Macy's (M) stake by 62% in Q2 2026, selling an estimated $13.7M and leaving 397,367 shares worth $9.36M. The position accounts for 0.56% of the portfolio, ranked #64.

Invenomic Capital Management first reported a position in M in Q4 2023 and has held it in 11 quarters since. The position peaked at $21.9M in Q2 2025. 489 funds tracked by Wall St. Rank hold M as of Q2 2026.

Invenomic Capital Management held 397,367 shares of Macy's worth $9.36M as of Q2 2026.
Invenomic Capital Management sold 653,956 Macy's shares in Q2 2026, an estimated $13.7M.
Macy's made up 0.56% of Invenomic Capital Management's portfolio in Q2 2026, its #64 holding.
Invenomic Capital Management first reported a position in Macy's in Q4 2023 and has held it in 11 quarters since.
Invenomic Capital Management's Macy's position peaked at $21.9M in Q2 2025.
489 funds tracked by Wall St. Rank held Macy's as of Q2 2026.

Based on Invenomic Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.